Hybrid Myxoinflammatory Fibroblastic Sarcoma/hemosiderotic Fibrolipomatous Tumor: Report of a Case Providing Further Evidence for a Pathogenetic Link
Overview
Affiliations
Myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor are rare, slow-growing soft tissue tumors of the distal extremities with recurrent potential. Recent cytogenetic studies have shown a t(1;10)(p22;q24) or der(10)t(1;10) in combination with aberrations of chromosome 3 in a limited number of cases of both entities. Here we report a case of a 42-year-old female with a soft tissue tumor of the ankle showing hybrid morphologic features of myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor, a der(10)t(1;10), and abnormalities of chromosome 3. This hybrid lesion provides further evidence for a close relationship between these 2 tumor types.
Myxoinflammatory fibroblastic sarcoma of the liver: Case report and literature review.
Li Y, Zhang L, Zheng G, Li J, Ma Z, Jia X Medicine (Baltimore). 2024; 103(27):e38796.
PMID: 38968455 PMC: 11224870. DOI: 10.1097/MD.0000000000038796.
Nishio J, Nakayama S, Aoki M Int J Mol Sci. 2024; 25(2).
PMID: 38256198 PMC: 10816835. DOI: 10.3390/ijms25021127.
Superficial CD34 Positive Fibroblastic Tumour with Myxoid Stroma.
Bruce-Brand C, Conradie W, Schneider J Int J Surg Pathol. 2022; 31(5):751-754.
PMID: 36221951 PMC: 10315862. DOI: 10.1177/10668969221126109.
Agaimy A, Meidenbauer N, Sukov W, Stoehr R, Vieth M, Roemer F Virchows Arch. 2021; 480(5):1115-1120.
PMID: 34389899 PMC: 9033724. DOI: 10.1007/s00428-021-03167-6.
Suster D, Michal M, Huang H, Ronen S, Springborn S, Debiec-Rychter M Mod Pathol. 2020; 33(12):2520-2533.
PMID: 32514165 DOI: 10.1038/s41379-020-0580-6.